Can a smartphone app ease the burden for young cancer survivors?
NCT ID NCT04593277
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed trial tested an interactive survivorship program for adolescent and young adult cancer survivors. The program included a mobile app, telehealth support, and printed materials to help survivors access healthcare resources, improve self-management skills, and reduce cancer-related distress. The study enrolled 549 survivors of various cancers like leukemia, lymphoma, melanoma, breast, thyroid, and colorectal cancer. Researchers measured changes in distress and healthcare adherence over 12 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- INSPIRE mobile application, control website, telehealth stepped care, printed survivorship materials
- What this could lead to
- If successful, this program could provide a practical way to help young cancer survivors manage their health after treatment and reduce emotional distress.
- What could go wrong
- This is a completed study, so results are available but may show limited or no benefit. The program may not work for all survivors or in all healthcare settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANATOMIC STAGE I BREAST CANCER AJCC V8 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, 98109, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California, 90095, United States
-
University of Pennsylvania/Abramson Cancer Center
Philadelphia, Pennsylvania, 19104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Genetic test may spare patients from unnecessary thyroid surgery
- Could muscle loss predict blood cancer outcomes?
- Can a Tumor's DNA guide better cancer care for kids?
- Can new drug cocktails reawaken the immune system against melanoma?
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can a new oral drug outsmart Radioiodine-Resistant thyroid cancer?